Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7301)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2019 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gountas I, Sypsa V, Papatheodoridis G, Souliotis K, Athanasakis K, Razavi H, Hatzakis A. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals. World J Gastroenterol 2019; 25(11): 1327-1340 [PMID: 30918426 DOI: 10.3748/wjg.v25.i11.1327] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i11/1327.htm |
| Number | Citing Articles |
| 1 |
Javier Crespo, Antonio Cuadrado, Christie Perelló, Joaquin Cabezas, Susana Llerena, Javier Llorca, Sergio Cedillo, Elba Llop, María Desamparados Escudero, Marta Hernández Conde, Laura Puchades, Carlos Redondo, José I. Fortea, Angel Gil de Miguel, Miguel A. Serra, Jeffrey V. Lazarus, José Luis Calleja. Epidemiology of hepatitis C virus infection in a country with universal access to direct‐acting antiviral agents: Data for designing a cost‐effective elimination policy in Spain. Journal of Viral Hepatitis 2020; 27(4): 360 doi: 10.1111/jvh.13238
|
| 2 |
G.V. Kochneva, M.Yu. Kartashov, E.I. Krivosheina, A.I. Kuznetsov, E.V. Chub, G.F. Sivolobova, S.V. Netesov. On the possibility of eradicating hepatitis C in Russia. Molecular Genetics Microbiology and Virology (Russian version) 2021; 39(1): 31 doi: 10.17116/molgen20213901131
|
| 3 |
Adam Trickey, Lindsey Hiebert, Chase Perfect, Caroline Thomas, Jean Luc El Kaim, Peter Vickerman, Carl Schȕtte, Robert Hecht. Hepatitis C virus elimination in Indonesia: Epidemiological, cost and cost‐effectiveness modelling to advance advocacy and strategic planning. Liver International 2020; 40(2): 286 doi: 10.1111/liv.14232
|
| 4 |
G. V. Kochneva, M. Yu. Kartashov, E. I. Krivosheina, A. I. Kuznetsov, E. V. Chub, G. F. Sivolobova, S. V. Netesov. On the Possibility of Eradicating Hepatitis C in Russia. Molecular Genetics, Microbiology and Virology 2021; 36(1): 27 doi: 10.3103/S0891416821010043
|
| 5 |
Perrine Roux, Cécile Donadille, Carine Magen, Eberhard Schatz, Richard Stranz, Adriana Curado, Tania Tsiakou, Ludmila Verdes, Aleksandrina Aleksova, Patrizia Carrieri, Salim Mezaache, Ben Charif Ali. Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe: a multi-country mixed-methods study. International Journal of Drug Policy 2021; 87: 102992 doi: 10.1016/j.drugpo.2020.102992
|
| 6 |
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatment. World Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
|
| 7 |
Janina Petkevičienė, Alexis Voeller, Eglė Čiupkevičienė, Devin Razavi-Shearer, Valentina Liakina, Ligita Jančorienė, Edita Kazėnaitė, Viačeslavas Zaksas, Gediminas Urbonas, Limas Kupčinskas. Hepatitis C screening in Lithuania: first-year results and scenarios for achieving WHO elimination targets. BMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-18470-5
|
| 8 |
Akshay Shetty, Michelle Lee, Julia Valenzuela, Sammy Saab. Cost effectiveness of hepatitis C direct acting agents. Expert Review of Pharmacoeconomics & Outcomes Research 2024; 24(5): 589 doi: 10.1080/14737167.2024.2348053
|
| 9 |
Javier Crespo, Agustín Albillos, María Buti, José Luis Calleja, Javier Garcia-Samaniego, Manuel Hernández-Guerra, Trinidad Serrano, Juan Turnes, Enrique Acín, Juan Berenguer, Marina Berenguer, Joan Colom, Inmaculada Fernández, Conrado Fernández Rodríguez, Xavier Forns, Federico García, Rafael Granados, Jeffrey Lazarus, Jose María Molero, Esther Molina, Fernando Pérez Escanilla, Juan A. Pineda, Manuel Rodríguez, Manuel Romero, Carlos Roncero, Pablo Saiz de la Hoya, Gloria Sánchez Antolín. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH). Gastroenterología y Hepatología (English Edition) 2019; 42(9): 579 doi: 10.1016/j.gastre.2019.09.002
|
| 10 |
Aya Olivia Nakitanda, Erika Duffell. Hospital discharges of hepatocellular carcinoma and non-alcohol related cirrhosis in the EU/EEA and United Kingdom: a descriptive analysis of 2004–2015 data. Infectious Diseases 2020; 52(11): 816 doi: 10.1080/23744235.2020.1799068
|
| 11 |
Ilias Gountas, Angelos Hatzakis, Georgios Nikolopoulos, Giota Touloumi, Kyriakos Souliotis. The cost of a late-detected outbreak among people who inject drugs. A modeling study. International Journal of Drug Policy 2021; 88: 103032 doi: 10.1016/j.drugpo.2020.103032
|
| 12 |
Eliminación de la hepatitis C. Documento de posicionamiento de la Asociación Española para el Estudio del Hígado (AEEH). Gastroenterología y Hepatología 2019; 42(9): 579 doi: 10.1016/j.gastrohep.2019.09.002
|
| 13 |
Ilias Gountas, Ioanna Yiasemi, Evi Kyprianou, Christos Mina, Chrysanthos Georgiou, Petros Katsioloudes, Andri Kouroufexi, Anna Demetriou, Elena Xenofontos, Georgios Nikolopoulos. Planning the hepatitis C virus elimination in Cyprus: A modeling study. World Journal of Gastroenterology 2021; 27(31): 5219-5231 doi: 10.3748/wjg.v27.i31.5219
|
| 14 |
Xiaoliang Xiong, Tongguang Ni. Analyzing the Influencing Factors of Economic Fluctuations in the Era of Big Data. Scientific Programming 2022; 2022: 1 doi: 10.1155/2022/9374025
|
| 15 |
Meiyu Wu, Jing Ma, Sini Li, Shuxia Qin, Chongqing Tan, Ouyang Xie, Andong Li, Aaron G. Lim, Xiaomin Wan. Effects and Costs of Hepatitis C Virus Elimination for the Whole Population in China: A Modelling Study. PharmacoEconomics 2024; 42(12): 1345 doi: 10.1007/s40273-024-01424-5
|
| 16 |
Gadeer Taha, Levy Ezra, Naim Abu-Freha. Hepatitis C Elimination: Opportunities and Challenges in 2023. Viruses 2023; 15(7): 1413 doi: 10.3390/v15071413
|